Elevance Health grew net profit 14.8% on revenue that rose only 1.4%

Elevance Health, a US health insurer, booked revenue of USD 51.4bn in the third quarter of 2026, 1.4% more than a year earlier. Net profit rose 14.8% to USD 1.4bn from USD 1.2bn. Operating profit went the other way: it slipped 2.0% to USD 1.3bn from USD 1.3bn, and the operating margin eased to 2.5% from 2.6%. So the gain in net profit did not come from the core business. The net margin widened to 2.7% from 2.3%.

The gap between operating and net profit usually comes from items below the operating line, such as investment income, interest and taxes. In an insurer, premiums are collected first and claims are paid later, so large balances sit in cash and securities and earn a return. Cash rose 18.8% to USD 10.3bn, while the equity ratio slipped to 35.0% from 35.8% as assets grew faster than equity. The accounts do not say what drove the profit above the operating line. I would watch that line before calling this an improvement.